At the molecular level, CPVT is characterized by genetic variants in two genes: the cardiac ryanodine receptor (cRyR) and cardiac calsequestrin 2 (CASQ2) [64]. Here, CASQ2 is linked to catecholaminergic polymorphic ventricular tachycardia.